secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELEFLEX INC (TFX)
CIK:        0000096943
Form:       8-K
Filed at:   2026-09-08T21:41:08+00:00
Accession:  0000096943-26-000101
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teleflex appoints Sean M. Salmon to board; expands to nine directors
--------------------------------------------------------------------

- Sean M. Salmon appointed to Teleflex board effective Sept 8, 2026; board grows from 8 to 9 directors.
- Salmon, 61, ex-Medtronic EVP & President of Cardiovascular (fiscal 2025 revenue ~$12.5B), brings 30+ yrs medtech experience.
- He also joins Growth and Operating Committee; 8 of 9 directors now independent; one-third of board refreshed in 2026.
- Salmon currently independent director at Adagio Medical (Nasdaq: ADGM); no related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/96943/000009694326000101/0000096943-26-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/96943/000009694326000101/tfx-20260908.htm
  HTML page:      https://secwatch.observer/filing/0000096943-26-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer